Silver Book Fact

High-intensity ultrasonic cyclocoagulation reduces intraocular pressure in refractory glaucoma patients.

Aptel F, Charrell T, Lafon C, Ramano F, et al. Miniaturized High-Intensity Focused Ultrasound Device in Patients with Glaucoma: A clinical pilot study. Invest Opthalmol Vis Sci. 2011; 52(12): 8747-8753. http://iovs.arvojournals.org/article.aspx?articleid=2187000

Reference

Title
Miniaturized High-Intensity Focused Ultrasound Device in Patients with Glaucoma: A clinical pilot study
Publication
Invest Opthalmol Vis Sci
Publication Date
2011
Authors
Aptel F, Charrell T, Lafon C, Ramano F, et al
Volume & Issue
Volume 52, Issue 12
Pages
8747-8753
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Of the 8 million older Americans at high risk of developing advanced age-related macular degeneration (AMD), 1.3 million will develop advanced AMD within 5 years. However, the NEI-sponsored Age-Related Eye…  
  • Lucentis to treat wet age-related macular degeneration (AMD)
    An FDA-approved ophthalmic drug that treats wet age-related macular degeneration (AMD)–ranibizumab (Lucentis)–maintained vision in 95% of clinical trial participants and improved vision by 15 or more letters in approximately 25%…  
  • A study on the impact of diet on age-related macular degeneration (AMD) found that those who took the highest amounts of carotenoids, such as lutein and zeaxanthin, had a 43%…  
  • Current treatments for proliferative diabetic retinopathy have reduced the rate of blindness within 5 years from 50% to less than 5%.  
  • Intensive glucose control (3 or more daily insulin injections or continuous subcutaneous insulin infusion) reduced the mean risk of retinopathy by 76% in type 1 diabetes patients who had not…